FDA Clears Abaloparatide for High-Risk Osteoporosis Patients
Abaloparatide is the first new anabolic treatment approved for postmenopausal women with osteoporosis in the United States in nearly 15 years. FDA Approvals …read more
Women’s Health, Access to Care Focus of ACOG 2017
The latest maternal mortality numbers and strategies to improve care will be discussed at the upcoming American Congress of Obstetricians and Gynecologists (ACOG) meeting. Medscape Medical News …read more
Standard test may miss urinary infection in symptomatic women
New research suggests that the majority of women with symptoms of urinary tract infection probably are infected, despite negative result on standard test. …read more
Migraine Tied to Hypertension Risk in Women
Women who have migraine headaches, particularly migraine without aura, are at increased risk for hypertension, a new study suggests. Medscape Medical News …read more